Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.147% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CC(CCc1ccccc1)NC(=O)C(=O)NCc1ccccc1
b. Cc1cccc(NC(=O)CCN2C(=O)c3ccccc3C2=O)n1
Answer: b. Cc1cccc(NC(=O)CCN2C(=O)c3ccccc3C2=O)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(NC(=O)CCN2C(=O)c3ccccc3C2=O)n1
Cc1cccc(NC(=O)CCN2C(=O)c3ccccc3C2=O)n1
3-(1,3-dioxoisoindol-2-yl)-N-(6-methylpyridin-2-yl)propanamide